Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Non-cash Items (2021 - 2024)

Gain Therapeutics (GANX) has 3 years of Non-cash Items data on record, last reported at $1.9 million in Q4 2024.

  • For Q4 2024, Non-cash Items changed N/A year-over-year to $1.9 million; the TTM value through Dec 2024 reached $1.9 million, changed N/A, while the annual FY2024 figure was $1.9 million, N/A changed from the prior year.
  • Non-cash Items reached $1.9 million in Q4 2024 per GANX's latest filing, up from $365881.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.6 million in Q2 2022 and bottomed at $2.6 in Q3 2021.
  • Average Non-cash Items over 3 years is $919401.2, with a median of $682379.0 recorded in 2021.
  • The widest YoY moves for Non-cash Items: up 14072246.15% in 2022, down 99.53% in 2022.
  • A 3-year view of Non-cash Items shows it stood at $163237.0 in 2021, then surged by 124.14% to $365881.0 in 2022, then skyrocketed by 421.24% to $1.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $1.9 million in Q4 2024, $365881.0 in Q3 2022, and $2.6 million in Q2 2022.